In our study, we found an increased risk of CVE associated with the use of ipratropium bromide in patients with COPD. We found a significant effect of recency of exposure to ipratropium bromide on ...

Time-dependent exposure to inhaled ipratropium bromide was characterized as exposed vs unexposed within the past year, and recency of exposure and cumulative exposure within the past year.